Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. It operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. This segment also distributes products to the diagnostic imaging sector. The Molecular Imaging segment provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.
| Market Capitalization | $258.2149 million |
| P/E Ratio | 0 |
| P/E Growth Ratio | 0 |
| Book Value | 0.372 |
| Dividend Per Share | 0.01 |
| Earnings Per Share | -0.08 |
| EBITDA | -6,550.968 |
| Profit Margin | -0.238 |
| Operating Margin TTM | -0.2474 |
| Return on Assets TTM | -0.0883 |
| Return on Equity TTM | -0.184 |
| Revenue TTM | 29,165.376 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2004-12-31 | 8,768 | 3,476 | ||
| 2005-12-31 | 9,126 | 2,028 | ||
| 2006-12-31 | 10,332 | 2,757 | ||
| 2007-12-31 | 11,128.224 | 3,121.918 | 8,006.306 | 6,494.367 |
| 2008-12-31 | 10,888.269 | 2,531.571 | 8,356.698 | 6,255.64 |
| 2009-12-31 | 13,112.42 | 2,546.484 | 10,565.936 | 7,651.662 |
| 2010-12-31 | 9,464.605 | 2,308.992 | 7,155.613 | 5,906.506 |
| 2011-12-31 | 10,314.506 | 3,127.65 | 7,186.856 | 7,250.515 |
| 2012-12-31 | 10,743.824 | 3,348.575 | 7,395.249 | 7,842.906 |
| 2013-12-31 | 11,882.134 | 3,508.337 | 8,373.797 | 8,933.352 |
| 2014-12-31 | 12,046.797 | 3,426.976 | 8,619.821 | 7,536.471 |
| 2015-12-31 | 12,582.519 | 2,671.671 | 9,910.848 | 7,815.394 |
| 2016-12-31 | 14,385.507 | 3,519.127 | 10,866.38 | 9,456.841 |
| 2017-12-31 | 13,188.752 | 2,647.649 | 10,541.103 | 12,262.333 |
| 2018-12-31 | 13,404.222 | 2,965.588 | 10,438.634 | 13,198.079 |
| 2019-12-31 | 14,078.801 | 2,908.664 | 11,170.137 | 17,434.919 |
| 2020-12-31 | 14,676.157 | 3,963.469 | 10,712.688 | 19,199.839 |
| 2021-12-31 | 17,704.574 | 5,042.295 | 12,662.279 | 19,614.875 |
| 2022-12-31 | 23,218.797 | 7,440.608 | 15,778.189 | 23,412.273 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2005-12-31 | 8,657.047 | 20,994.769 | 9,655.089 | 14,698.869 | ||
| 2006-12-31 | 1,403 | 9,206 | 9,772 | 4,975 | 6,515 | |
| 2007-12-31 | 1,204.543 | 10,977.549 | 3,635.405 | 1,512 | 7,841.223 | |
| 2008-12-31 | 4,206.271 | 18,579.649 | 5,524.093 | 2,733 | 10,867.403 | |
| 2009-12-31 | 4,612.205 | 19,644.411 | 5,715.77 | 1,757.35 | 976 | 11,088.908 |
| 2010-12-31 | 1,541.644 | 22,141.899 | 8,375.745 | 6,078.3 | 24 | 11,088.908 |
| 2011-12-31 | 2,043.814 | 21,293.213 | 6,688.414 | 4,803.156 | 21 | 13,065.192 |
| 2012-12-31 | 2,346.556 | 21,656.363 | 6,047.93 | 3,604.31 | 17 | 14,966.515 |
| 2013-12-31 | 1,220.646 | 11,899.167 | 5,348.674 | 2,416.986 | 14,963.237 | |
| 2014-12-31 | 3,268.425 | 10,961.317 | 3,205.157 | 45.692 | 200 | 14,962.967 |
| 2015-12-31 | 6,444.995 | 16,540.917 | 3,438.674 | 45.877 | 151.5 | 14,962.967 |
| 2016-12-31 | 4,590.76 | 16,414.994 | 3,953.191 | 0 | 0 | 14,962.967 |
| 2017-12-31 | 8,689.676 | 23,377.241 | 6,127.849 | 87.536 | 5.61 | 21,551.727 |
| 2018-12-31 | 5,854.959 | 23,536.721 | 6,520.752 | 120.577 | 0 | 21,905.035 |
| 2019-12-31 | 12,660.323 | 32,528.417 | 9,324.472 | 172.582 | 31,576.003 | |
| 2020-12-31 | 1,874.285 | 28,275.125 | 11,159.275 | 148.567 | 31,632.219 | |
| 2021-12-31 | 29,249.255 | 55,740.904 | 12,673.17 | 178.265 | 62,974.44 | |
| 2022-12-31 | 20,296.176 | 49,542.151 | 13,005.541 | 209.992 | 63,420.81 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2004-12-31 | 2,147 | 1,920 | ||||
| 2005-12-31 | 1,582 | 1,471 | ||||
| 2006-12-31 | 2,028 | 1,169 | 1,403.328 | |||
| 2007-12-31 | 1,131.239 | 146 | -198.785 | 1,403.328 | 1,204.543 | |
| 2008-12-31 | 1,757.062 | 1,486 | 3,001.728 | 1,204.543 | 4,206.271 | |
| 2009-12-31 | 2,044.49 | 3,691 | 405.934 | 4,206.271 | 4,612.205 | |
| 2010-12-31 | 450.106 | -3,070.561 | 4,612.205 | 1,541.644 | ||
| 2011-12-31 | -956.22 | 564 | 502.17 | 1,541.644 | 2,043.814 | |
| 2012-12-31 | -1,044.127 | 369 | 302.742 | 2,043.814 | 2,346.556 | |
| 2013-12-31 | -9,640.117 | 1,185 | -1,125.91 | 2,346.556 | 1,220.646 | 278.309 |
| 2014-12-31 | 4,065.563 | 4,469 | 2,047.779 | 1,220.646 | 3,268.425 | 278.309 |
| 2015-12-31 | 4,793.047 | 4,154.83 | 3,176.57 | 3,268.425 | 6,444.995 | 278.309 |
| 2016-12-31 | 891.368 | 654.794 | -1,854.235 | 6,444.995 | 4,590.76 | 556.618 |
| 2017-12-31 | -1,524.571 | -682.121 | 4,098.916 | 4,590.76 | 8,689.676 | 600.122 |
| 2018-12-31 | -35.456 | -1,107.335 | -2,834.717 | 8,689.676 | 5,854.959 | 651.472 |
| 2019-12-31 | -2,912.44 | -489.34 | 6,805.364 | 5,854.959 | 12,660.323 | 660.501 |
| 2020-12-31 | -6,043.636 | -8,934.868 | -10,786.038 | 12,660.323 | 1,874.285 | 752.419 |
| 2021-12-31 | -5,040.166 | -1,629.41 | 27,374.97 | 1,874.285 | 29,249.255 | 881.319 |
| 2022-12-31 | -6,611.515 | -5,680.031 | -8,953.079 | 29,249.255 | 20,296.176 | 882.592 |